[go: up one dir, main page]

TR201001902A2 - Uzatılmış salınımlı trimetazidin tablet - Google Patents

Uzatılmış salınımlı trimetazidin tablet

Info

Publication number
TR201001902A2
TR201001902A2 TR2010/01902A TR201001902A TR201001902A2 TR 201001902 A2 TR201001902 A2 TR 201001902A2 TR 2010/01902 A TR2010/01902 A TR 2010/01902A TR 201001902 A TR201001902 A TR 201001902A TR 201001902 A2 TR201001902 A2 TR 201001902A2
Authority
TR
Turkey
Prior art keywords
trimetazidine
tablets
extended release
trimethaside
prepared
Prior art date
Application number
TR2010/01902A
Other languages
English (en)
Inventor
Bulgur Abdullah
Original Assignee
Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. filed Critical Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş.
Priority to TR2010/01902A priority Critical patent/TR201001902A2/tr
Priority to PCT/TR2010/000173 priority patent/WO2011112160A1/en
Publication of TR201001902A2 publication Critical patent/TR201001902A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Polietilen oksit polimeri kullanılarak direk baskı yöntemi ile hazırlanmış Trimetazidin kontrollü salınım formu ile ilgilidir Formülasyon sindirim sisteminin pH aralığında sabit bir salınım profili venr ve safsızlıklar açısından stabilize edilmiştir
TR2010/01902A 2010-03-12 2010-03-12 Uzatılmış salınımlı trimetazidin tablet TR201001902A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2010/01902A TR201001902A2 (tr) 2010-03-12 2010-03-12 Uzatılmış salınımlı trimetazidin tablet
PCT/TR2010/000173 WO2011112160A1 (en) 2010-03-12 2010-09-01 Extended release trimetazidine tablets

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/01902A TR201001902A2 (tr) 2010-03-12 2010-03-12 Uzatılmış salınımlı trimetazidin tablet

Publications (1)

Publication Number Publication Date
TR201001902A2 true TR201001902A2 (tr) 2011-04-21

Family

ID=43244791

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/01902A TR201001902A2 (tr) 2010-03-12 2010-03-12 Uzatılmış salınımlı trimetazidin tablet

Country Status (2)

Country Link
TR (1) TR201001902A2 (tr)
WO (1) WO2011112160A1 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102885795A (zh) * 2012-10-31 2013-01-23 广州帝奇医药技术有限公司 盐酸曲美他嗪缓释片及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625055B2 (ja) 1985-03-18 1994-04-06 日本ケミフア株式会社 持続性錠剤
FR2717687B1 (fr) 1994-03-24 1996-06-14 Adir Compositions pharmaceutiques permettant la libération prolongée de trimétazidine après administration par voie orale.
FR2802424B1 (fr) 1999-12-17 2002-02-15 Adir Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale
DE60042972D1 (de) 2000-10-05 2009-10-29 Usv Ltd Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
WO2003043610A2 (en) 2001-11-21 2003-05-30 Themis Laboratories Private Limited A process for manufacture of a sustained release composition containing microbe
FR2885807B1 (fr) * 2005-05-18 2008-05-16 Mg Pharma Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl) piperazine, et procede de preparation
BRPI0815602A2 (pt) * 2007-08-08 2015-03-03 Usv Ltd Composições de liberação prolongada de trimetazidina e processo para a preparação das mesmas
EP2200591A2 (en) 2007-09-11 2010-06-30 Ranbaxy Laboratories Limited Controlled release pharmaceutical dosage forms of trimetazidine

Also Published As

Publication number Publication date
WO2011112160A1 (en) 2011-09-15

Similar Documents

Publication Publication Date Title
UA117362C2 (uk) Модулятори метил-модифікуючих ферментів, композиції та їх застосування
DOP2014000203A (es) Compuestos de heterociclilo
ECSP14027269A (es) Picolinamidas macrocíclicas como fungicidas
TR201909389T4 (tr) Terapötik nanopartikülleri hazırlamaya yönelik proses.
MX2013006034A (es) Compuestos capaces de liberar compuestos fragantes.
FR2997562B1 (fr) Plaque bipolaire pour pile a combustible
CR20120033A (es) Derivados de 5-fluoro-2-oxopirimidina-1-(2h) carboxilato.
AR085482A1 (es) Polimero colorante
EP2827402A4 (en) PERFORMANCE MEMORY
PH12014501240A1 (en) Film containing compositions
MX340436B (es) Formulacion farmaceutica estable con descoloramiento limitado.
CO7200262A2 (es) Nueva dosificación y formulación
EA201300733A1 (ru) Рекомбинантные микобактерии в качестве вакцины
EP2817070A4 (en) COSMETIC COMPOSITIONS CONTAINING A PREPARATION OF CELL CULTURE OF ARCTIC BROWN
FR2985382B1 (fr) Pile a combustible
EP2850662A4 (en) BACK PV FILM
TR201100150A2 (tr) Suda çözünür dozaj formları
TR201100148A2 (tr) Stabil akarboz förmülasyonları.
PH12014501840A1 (en) Pharmaceutical formulation having improved stability
FR2997561B1 (fr) Plaque bipolaire pour pile a combustible
ZA201505170B (en) Tablets with improved acceptance and good storage stability
TR201001902A2 (tr) Uzatılmış salınımlı trimetazidin tablet
EP2768048A4 (en) ALKALIC CELL
EP2713424A4 (en) ALKALINE BATTERY
CO7151505A2 (es) Formulación oral